Vikas Gupta

Vikas Gupta is an experienced leader in the biopharmaceutical industry, currently serving as President of ReciBioPharm within the Biologics Business Unit at Recipharm since May 2023. Previously, Vikas held various leadership positions at Repligen Corporation from March 2016 to April 2023, including Vice President and General Manager of Gene Therapy and Downstream Bioprocessing, where responsibilities encompassed global management of gene therapy portfolios and downstream bioprocessing businesses. Vikas also served as Vice President and General Manager of Strategic Growth Initiatives and Vice President of Business Development & Strategy during tenure at Repligen. Prior experience includes leadership roles at GE Healthcare and Millipore, focusing on bioprocessing solutions, product management, and business development. Vikas began a career at Bayer Diagnostics in financial planning and analysis. Educational qualifications include an MS in Finance from Bentley University, an MBA from the Institute of Management Technology, and a Bachelor's degree in Chemical Engineering from Malaviya National Institute of Technology Jaipur.